GLASGOW—Periurethral injections of polyacrylamid hydrogel (PAHG), a new bulking agent, are a safe and effective option as a salvage therapy for women with severe stress urinary incontinence (SUI) ...
Gastro-oesophageal reflux disease (GORD) is a common condition that can have a significant impact on the quality of life of an individual. It is caused by failure of the sphincter mechanism at the ...
We have moved interventional procedures guidance 210 to become HealthTech guidance 135. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment ...
Jan. 13, 2006 -- The US Food and Drug Administration (FDA) approved in 2005 an injectable bulking agent for the treatment of stress urinary incontinence in women with intrinsic sphincteric deficiency; ...
Before 1970, attempts had been made at injecting materials into the urethral wall to relieve incontinence, generally with poor results. Then, in the early 1970s, Solomon Berg reported on the use of ...
SOLESTA injectable gel by Oceana Therapeutics The FDA has approved Solesta gel (Oceana Therapeutics), a biocompatible tissue bulking agent consisting of dextranomer microspheres and stabilized sodium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results